Page last updated: 2024-08-22

buthionine sulfoximine and transferrin

buthionine sulfoximine has been researched along with transferrin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hawkins, C; Ponka, P; Richardson, DR; Watts, RN1
Gong, S; Hu, Y; Lu, M; Luo, Y; Ma, XN; Tian, J; Wu, Y; Xu, Z; Yu, BY; Yu, XA; Zhang, Y1

Other Studies

2 other study(ies) available for buthionine sulfoximine and transferrin

ArticleYear
Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, May-16, Volume: 103, Issue:20

    Topics: Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Cell Line; Cell Proliferation; Enzyme Inhibitors; Glutathione; Humans; Iron; Iron Radioisotopes; Mice; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Spermine; Temperature; Transferrin

2006
A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress.
    Theranostics, 2020, Volume: 10, Issue:1

    Topics: Animals; Artemisinins; Buthionine Sulfoximine; Drug Carriers; Female; Glutathione; Hep G2 Cells; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oxidation-Reduction; Oxidative Stress; Precision Medicine; Reactive Oxygen Species; Transferrin

2020